Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-01-09

Clinical Trial Update: Study of AxoGuard® Nerve Cap and Neurectomy for Treatment of Symptomatic Neuroma & Prevention of Recurrent Neuroma Pain [NA]

View source ↗

Summary

Completed clinical trial evaluating AxoGuard Nerve Cap with neurectomy for symptomatic neuroma and prevention of recurrent neuroma pain; results have been poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AxoGuard Nerve Cap

Snippet

Sponsor: Axogen Corporation | Conditions: Symptomatic Neuroma, Morton's Neuroma | NA | Status: COMPLETED | Results posted: 2025-01-09